OprF protein, Pseudomonas aeruginosa

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2010
0119972010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Vaccination against Pseudomonas aeruginosa is a desirable, yet challenging strategy for prevention of airway infection in… (More)
Is this relevant?
2004
2004
We constructed an oral live vaccine based on the attenuated aroA mutant Salmonella enterica serovar Typhimurium strain SL3261… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2004
2004
A vaccine against Pseudomonas aeruginosa based on recombinant outer membranes has been developed. After intramuscularly injecting… (More)
Is this relevant?
2003
2003
In a recent clinical trial we evaluated the safety and immunogenicity of a recombinant OprF-OprI vaccine consisting of the mature… (More)
Is this relevant?
1999
1999
A hybrid protein [Met-Ala-(His)6OprF190-342-OprI21-83] consisting of the mature outer membrane protein I (OprI) and amino acids… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1997
1997
Recently a hybrid protein containing parts of the outer membrane proteins OprF (aa 190-342) and OprI (aa 21-83) from Pseudomonas… (More)
Is this relevant?